The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1

BACKGROUND: Heat shock protein 90 (HSP90) inhibitors have emerged as a promising class of anti-cancer drugs in both solid and hematologic malignancies. The HSP90 family includes the cytosolic HSP90 (HSP90AA1), the ER paralogue gp96 (HSP90B1) and the mitochondrial member TRAP1 (HSP90L). We evaluated...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Usmani, Saad Z, Bona, Robert D, Chiosis, Gabriela, Li, Zihai
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974653/
https://ncbi.nlm.nih.gov/pubmed/20977755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-3-40
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky